Trial Details
COMPLETEDBasic Information
| Clinical ID | c1177 |
|---|---|
| Identifier | NCT00063414 |
| Trial Title | ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Alicaforsen |
Participant Information
| Sponsor | Ionis Pharmaceuticals, Inc. |
|---|---|
| City | Chicago |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2002-11-20 |
|---|---|
| Primary Completion Date | 2005-03-24 |
| Completion Date | 2005-03-24 |